Clinical Trials ·
This study aims to assess how retatrutide influences the pharmacokinetics of metoprolol in healthy individuals. Understanding this interaction is crucial for evaluating the safety and efficacy of retatrutide, particularly in populations that may be using metoprolol for cardiovascular conditions.
What this source covers
The study identified by the ClinicalTrials.gov identifier NCT06808802 is designed to investigate the pharmacokinetic effects of retatrutide (LY3437943) on metoprolol in healthy participants. This clinical trial will provide insights into how retatrutide may alter the absorption, distribution, metabolism, and excretion of metoprolol, a commonly prescribed beta-blocker.
Why it matters for Retatrutide research
Understanding the pharmacokinetic interactions between retatrutide and other medications, such as metoprolol, is essential for clinicians and researchers. As retatrutide is explored for its potential benefits in metabolic and cardiometabolic health, knowledge of its interactions with existing medications can inform treatment protocols and patient safety considerations.
Key findings or claims
- The study focuses on the pharmacokinetics of metoprolol when administered with retatrutide.
- Healthy participants will be the subjects of this investigation.
- The study aims to clarify any significant alterations in metoprolol's pharmacokinetic profile due to retatrutide.
Context and prior work
Retatrutide is part of a new class of medications that target multiple pathways involved in metabolic regulation, including GLP-1, GIP, and glucagon receptors. Previous studies have indicated that GLP-1 receptor agonists can influence the pharmacokinetics of other drugs, particularly those metabolized by the liver. This trial will contribute to the growing body of literature examining how retatrutide interacts with other pharmacological agents, which is critical for its integration into treatment regimens.
Practical takeaways for researchers
Researchers should consider the implications of pharmacokinetic interactions when studying retatrutide, especially in populations taking multiple medications. The findings from this trial could help guide future research directions and enhance understanding of retatrutide's role in therapeutic settings. Additionally, the results may inform clinical guidelines regarding the co-administration of retatrutide and metoprolol.
FAQ
What is the purpose of the study on retatrutide and metoprolol?
The study aims to measure the effect of retatrutide on the pharmacokinetics of metoprolol in healthy participants.
Who are the participants in this study?
The participants in this clinical trial are healthy individuals.
Why is understanding pharmacokinetics important?
Understanding pharmacokinetics is crucial for determining how a drug behaves in the body, which can affect its efficacy and safety, especially when used in combination with other medications.
Source: ClinicalTrials.gov · NCT06808802 · published 2025-06-05.